Malaysia vs Netherlands: Treatment for hypertension, female
Malaysia
45.5%
in 2019
Netherlands
46.5%
in 2019
Malaysia rank
108th
Netherlands rank
105th
Treatment for hypertension, female over time
- Malaysia
- Netherlands
How they compare
Netherlands currently reports 46.5% against 45.5% in Malaysia, a difference of 1.0%.
The two have swapped places 2 times across 30 shared years of data; in 1990 it was Netherlands ahead.
Malaysia ranks 108th and Netherlands ranks 105th of 192 countries.
Across the 3 decades both report, Malaysia averaged higher in 1 and Netherlands in 2.
Head to head by decade
| Decade | Malaysia | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 25.5% | 28.9% | 3.4% | Netherlands |
| 2000s | 37.8% | 37.0% | 0.7% | Malaysia |
| 2010s | 45.0% | 45.1% | 0.1% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment for hypertension, female, Malaysia or Netherlands?
- Netherlands, at 46.5% against 45.5% in Malaysia as of 2019.
- What is the difference in treatment for hypertension, female between Malaysia and Netherlands?
- 1.0%, with Netherlands ahead.
- How many years of comparable data are there for Malaysia and Netherlands?
- 30 years are reported by both, from 1990 to 2019.
- How do Malaysia and Netherlands rank globally for treatment for hypertension, female?
- Malaysia ranks 108th and Netherlands ranks 105th of 192 countries.
- Where does this data come from?
- World Health Organization's Global Health Observatory Data Repository, published as Treatment for hypertension, female (% of female adults ages 30-79 with hypertension). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Treatment for hypertension is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.